Related Experiment Video
Updated: Mar 23, 2026
Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease
Published on: December 26, 2016
M2 Macrophage Transplantation Ameliorates Cognitive Dysfunction in Amyloid-β-Treated Rats Through Regulation of
Abstract:
Alzheimer's disease (AD) is the most common neurodegenerative disorder in the elderly population. Neuroinflammation induced by amyloid-β (Aβ) aggregation is considered to be the critical factor underlying AD pathological mechanisms. Alternatively activated (M2) macrophages/microglia have been reported to have neuroprotective effects in neurodegenerative disease. In this study, we characterized the neuroprotective effects of M2 macrophage transplantation in AD model rats and investigated the underlying mechanisms. Intracerebroventricular injection of Aβ1 - 42 to rats was used to model AD and resulted in cognitive impairment, neuronal damage, and inflammatory changes in the brain microenvironment. We observed an increased interferon regulatory factor (IRF) 5/IRF4 ratio, resulting in greater production of classically activated (M1) versus M2 microglia. M2 macrophage transplantation attenuated inflammation in the brain, reversed Aβ1 - 42-induced changes in the IRF4-IRF5 ratio, drove endogenous microglial polarization toward the M2 phenotype, and ameliorated cognitive impairment. Nerve growth factor (NGF) treatment reduced the IRF5/IRF4 ratio and induced primary microglial polarization to the M2 phenotype in vitro; these effects were prevented by tyrosine Kinase Receptor A (TrkA) inhibition. M2 macrophage transplantation restored the balance of IRF4-IRF5 by affecting the expression of NGF and inflammatory cytokines in the brains of AD model rats. This drove microglial polarization to the M2 phenotype, promoted termination of neuroinflammation, and resulted in improved cognitive abilities.
Insights
Transplanting M2 macrophages into Alzheimer
Area of Science:
- Neuroscience
- Immunology
- Cell Biology
Background:
- Alzheimer's disease (AD) is a prevalent neurodegenerative disorder linked to neuroinflammation from amyloid-beta (Aβ) aggregation.
- Classically activated (M1) microglia exacerbate AD, while alternatively activated (M2) macrophages/microglia show neuroprotective potential.
Purpose of the Study:
- To investigate the neuroprotective effects of M2 macrophage transplantation in an Alzheimer's disease rat model.
- To elucidate the underlying mechanisms, focusing on microglial polarization and neuroinflammation modulation.
Main Methods:
- Alzheimer's disease model induced via intracerebroventricular injection of Aβ1–42 in rats.
- M2 macrophage transplantation into the brain.
- Analysis of interferon regulatory factor (IRF) 5/IRF4 ratio, microglial phenotype, nerve growth factor (NGF) expression, and cognitive function.
Main Results:
- M2 macrophage transplantation reduced brain inflammation and reversed the increased IRF5/IRF4 ratio observed in AD rats.
- Transplanted M2 macrophages promoted endogenous microglial polarization towards the M2 phenotype.
- Cognitive impairment was ameliorated, and NGF treatment in vitro also induced M2 polarization, dependent on TrkA signaling.
Conclusions:
- M2 macrophage transplantation effectively reduces neuroinflammation in AD models by restoring IRF4-IRF5 balance and promoting M2 microglial polarization.
- This approach ameliorates cognitive deficits, highlighting M2 macrophages as a potential therapeutic strategy for Alzheimer's disease.
